 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CNBX Pharmaceuticals, Inc. is a clinical stage company, which engages in the discovery, development, and commercialization of cannabinoid-based products and technologies for the treatment of cancer. Its products include Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS), and RCC-33, an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC). The company was founded by Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.

Watchers	482
52-Wk Low	$0.0097
52-Wk High	$4.00

Market Cap	$204,405.00
Volume (M)	274,925.00
52-Wk High	$4.00
52-Wk Low	$0.0097

CNBX CNBX Pharmaceuticals Inc

About

Feed

News

Fundamentals